Viewing Study NCT05286060


Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2025-12-27 @ 11:17 PM
Study NCT ID: NCT05286060
Status: RECRUITING
Last Update Posted: 2025-06-15
First Post: 2022-03-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of the Combination of GX-188E Vaccination, GX-I7 and Pembrolizumab in Patients With Advanced, Resectable HPV Type 16 and/or 18 Positive Head and Neck Cancer
Sponsor: Yonsei University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module